(CGIX) |
| 0 (0%) 10-10 04:00 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 7.48 |
| Resistance 1: | 6.27 |
| Pivot price: | 5.84 |
| Support 1: | 4.30 |
| Support 2: | 3.58 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.341 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 23 Jul 2024
Tanager collaborates with Financial Software - Private Banker International
Wed, 31 Mar 2021
Cancer Genetics and StemoniX Announce Merger Closing - GlobeNewswire
Wed, 23 Sep 2020
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors - GlobeNewswire
Wed, 02 Sep 2020
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors - GlobeNewswire
Tue, 01 Sep 2020
Paving the way for the future of drug discovery - Nature
Wed, 20 Nov 2019
Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update - GlobeNewswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
